DCVC Bio — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Novome Biotechnologiesnovomebio.comNov 2016 · $33M
South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.
Daly City, US
Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)
BoardElizabeth Stanley(Director)
Co-investorsAlta PartnersCerity Partners VenturesColorcon Ventures5AM VenturesAlexandriaDCVC (Data Collective)+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

